High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series
Abstract We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2 ) up to 1.0 (100%). Oxygenation was insuffi...
Gespeichert in:
| Veröffentlicht in: | Respiratory investigation 2016-03, Vol.54 (2), p.125-129 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 129 |
|---|---|
| container_issue | 2 |
| container_start_page | 125 |
| container_title | Respiratory investigation |
| container_volume | 54 |
| creator | Horio, Yukihiro Takihara, Takahisa Niimi, Kyoko Komatsu, Masamichi Sato, Masako Tanaka, Jun Takiguchi, Hiroto Tomomatsu, Hiromi Tomomatsu, Katsuyoshi Hayama, Naoki Oguma, Tsuyoshi Aoki, Takuya Urano, Tetsuya Takagi, Atsushi Asano, Koichiro |
| description | Abstract We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2 ) up to 1.0 (100%). Oxygenation was insufficient under non-rebreathing face masks; however, the introduction of HFNC with an FIO2 of 0.7–1.0 (flow rate: 40 L/min) improved oxygenation and was well-tolerated until the partial pressure of oxygen in blood/FIO2 ratio increased (between 21 and 26 days). Thus, HFNC might be an effective and well-tolerated therapeutic addition to the management of AEIP. |
| doi_str_mv | 10.1016/j.resinv.2015.09.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765918075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S221253451500115X</els_id><sourcerecordid>1765918075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-f14681c3afdd4bacad4dd023bf18f388dab9d57c14496ae07f5d7619b9130fe13</originalsourceid><addsrcrecordid>eNqFkT9vFDEQxS0EIlHIN0DIJc0unrW9fyiQoigQpEgUgERnee1x4mPPPmxvyH17fLqQgoZpZor33mh-Q8hrYC0w6N9t2oTZh_u2YyBbNrWMyWfktOugaySX_PnTLOQJOc95w2r1shPQvyQnXT8Okxj5KXHX_vaucUv8TYPOeqFGh7AumsaH_S0GWu4w6d2eupioNmtBig_aYJp18THQ6KgPBVMuvvjq3gVctzF4_Z5e1KiMNGPymF-RF04vGc8f-xn5_vHq2-V1c_Pl0-fLi5vGyGEojQPRj2C4dtaKWRtthbWs47OD0fFxtHqerBwMCDH1GtngpB16mOYJOHMI_Iy8PebuUvy1Yi5q67PBZdEB45oVDL2cYGSDrFJxlJoUc07o1C75rU57BUwdIKuNOkJWB8iKTapCrrY3jxvWeYv2yfQXaRV8OAqw3nnvMalsPAaD1ic0Rdno_7fh3wCz-OCNXn7iHvMmrilUhgpU7hRTXw-PPvwZJGMA8gf_Ay-UpgY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765918075</pqid></control><display><type>article</type><title>High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Horio, Yukihiro ; Takihara, Takahisa ; Niimi, Kyoko ; Komatsu, Masamichi ; Sato, Masako ; Tanaka, Jun ; Takiguchi, Hiroto ; Tomomatsu, Hiromi ; Tomomatsu, Katsuyoshi ; Hayama, Naoki ; Oguma, Tsuyoshi ; Aoki, Takuya ; Urano, Tetsuya ; Takagi, Atsushi ; Asano, Koichiro</creator><creatorcontrib>Horio, Yukihiro ; Takihara, Takahisa ; Niimi, Kyoko ; Komatsu, Masamichi ; Sato, Masako ; Tanaka, Jun ; Takiguchi, Hiroto ; Tomomatsu, Hiromi ; Tomomatsu, Katsuyoshi ; Hayama, Naoki ; Oguma, Tsuyoshi ; Aoki, Takuya ; Urano, Tetsuya ; Takagi, Atsushi ; Asano, Koichiro</creatorcontrib><description>Abstract We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2 ) up to 1.0 (100%). Oxygenation was insufficient under non-rebreathing face masks; however, the introduction of HFNC with an FIO2 of 0.7–1.0 (flow rate: 40 L/min) improved oxygenation and was well-tolerated until the partial pressure of oxygen in blood/FIO2 ratio increased (between 21 and 26 days). Thus, HFNC might be an effective and well-tolerated therapeutic addition to the management of AEIP.</description><identifier>ISSN: 2212-5345</identifier><identifier>EISSN: 2212-5353</identifier><identifier>DOI: 10.1016/j.resinv.2015.09.005</identifier><identifier>PMID: 26879483</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute Disease ; Acute exacerbation ; Acute respiratory failure ; Aged ; Aged, 80 and over ; Cannula ; Disease Progression ; High-flow nasal cannula ; Humans ; Internal Medicine ; Interstitial pneumonia ; Lung Diseases, Interstitial - therapy ; Male ; Oxygen Inhalation Therapy - instrumentation ; Oxygen Inhalation Therapy - methods ; Oxygen therapy ; Pulmonary/Respiratory ; Treatment Outcome</subject><ispartof>Respiratory investigation, 2016-03, Vol.54 (2), p.125-129</ispartof><rights>The Japanese Respiratory Society</rights><rights>2015 The Japanese Respiratory Society</rights><rights>Copyright © 2015 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-f14681c3afdd4bacad4dd023bf18f388dab9d57c14496ae07f5d7619b9130fe13</citedby><cites>FETCH-LOGICAL-c577t-f14681c3afdd4bacad4dd023bf18f388dab9d57c14496ae07f5d7619b9130fe13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26879483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horio, Yukihiro</creatorcontrib><creatorcontrib>Takihara, Takahisa</creatorcontrib><creatorcontrib>Niimi, Kyoko</creatorcontrib><creatorcontrib>Komatsu, Masamichi</creatorcontrib><creatorcontrib>Sato, Masako</creatorcontrib><creatorcontrib>Tanaka, Jun</creatorcontrib><creatorcontrib>Takiguchi, Hiroto</creatorcontrib><creatorcontrib>Tomomatsu, Hiromi</creatorcontrib><creatorcontrib>Tomomatsu, Katsuyoshi</creatorcontrib><creatorcontrib>Hayama, Naoki</creatorcontrib><creatorcontrib>Oguma, Tsuyoshi</creatorcontrib><creatorcontrib>Aoki, Takuya</creatorcontrib><creatorcontrib>Urano, Tetsuya</creatorcontrib><creatorcontrib>Takagi, Atsushi</creatorcontrib><creatorcontrib>Asano, Koichiro</creatorcontrib><title>High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series</title><title>Respiratory investigation</title><addtitle>Respir Investig</addtitle><description>Abstract We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2 ) up to 1.0 (100%). Oxygenation was insufficient under non-rebreathing face masks; however, the introduction of HFNC with an FIO2 of 0.7–1.0 (flow rate: 40 L/min) improved oxygenation and was well-tolerated until the partial pressure of oxygen in blood/FIO2 ratio increased (between 21 and 26 days). Thus, HFNC might be an effective and well-tolerated therapeutic addition to the management of AEIP.</description><subject>Acute Disease</subject><subject>Acute exacerbation</subject><subject>Acute respiratory failure</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cannula</subject><subject>Disease Progression</subject><subject>High-flow nasal cannula</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Interstitial pneumonia</subject><subject>Lung Diseases, Interstitial - therapy</subject><subject>Male</subject><subject>Oxygen Inhalation Therapy - instrumentation</subject><subject>Oxygen Inhalation Therapy - methods</subject><subject>Oxygen therapy</subject><subject>Pulmonary/Respiratory</subject><subject>Treatment Outcome</subject><issn>2212-5345</issn><issn>2212-5353</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT9vFDEQxS0EIlHIN0DIJc0unrW9fyiQoigQpEgUgERnee1x4mPPPmxvyH17fLqQgoZpZor33mh-Q8hrYC0w6N9t2oTZh_u2YyBbNrWMyWfktOugaySX_PnTLOQJOc95w2r1shPQvyQnXT8Okxj5KXHX_vaucUv8TYPOeqFGh7AumsaH_S0GWu4w6d2eupioNmtBig_aYJp18THQ6KgPBVMuvvjq3gVctzF4_Z5e1KiMNGPymF-RF04vGc8f-xn5_vHq2-V1c_Pl0-fLi5vGyGEojQPRj2C4dtaKWRtthbWs47OD0fFxtHqerBwMCDH1GtngpB16mOYJOHMI_Iy8PebuUvy1Yi5q67PBZdEB45oVDL2cYGSDrFJxlJoUc07o1C75rU57BUwdIKuNOkJWB8iKTapCrrY3jxvWeYv2yfQXaRV8OAqw3nnvMalsPAaD1ic0Rdno_7fh3wCz-OCNXn7iHvMmrilUhgpU7hRTXw-PPvwZJGMA8gf_Ay-UpgY</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Horio, Yukihiro</creator><creator>Takihara, Takahisa</creator><creator>Niimi, Kyoko</creator><creator>Komatsu, Masamichi</creator><creator>Sato, Masako</creator><creator>Tanaka, Jun</creator><creator>Takiguchi, Hiroto</creator><creator>Tomomatsu, Hiromi</creator><creator>Tomomatsu, Katsuyoshi</creator><creator>Hayama, Naoki</creator><creator>Oguma, Tsuyoshi</creator><creator>Aoki, Takuya</creator><creator>Urano, Tetsuya</creator><creator>Takagi, Atsushi</creator><creator>Asano, Koichiro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160301</creationdate><title>High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series</title><author>Horio, Yukihiro ; Takihara, Takahisa ; Niimi, Kyoko ; Komatsu, Masamichi ; Sato, Masako ; Tanaka, Jun ; Takiguchi, Hiroto ; Tomomatsu, Hiromi ; Tomomatsu, Katsuyoshi ; Hayama, Naoki ; Oguma, Tsuyoshi ; Aoki, Takuya ; Urano, Tetsuya ; Takagi, Atsushi ; Asano, Koichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-f14681c3afdd4bacad4dd023bf18f388dab9d57c14496ae07f5d7619b9130fe13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Disease</topic><topic>Acute exacerbation</topic><topic>Acute respiratory failure</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cannula</topic><topic>Disease Progression</topic><topic>High-flow nasal cannula</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Interstitial pneumonia</topic><topic>Lung Diseases, Interstitial - therapy</topic><topic>Male</topic><topic>Oxygen Inhalation Therapy - instrumentation</topic><topic>Oxygen Inhalation Therapy - methods</topic><topic>Oxygen therapy</topic><topic>Pulmonary/Respiratory</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horio, Yukihiro</creatorcontrib><creatorcontrib>Takihara, Takahisa</creatorcontrib><creatorcontrib>Niimi, Kyoko</creatorcontrib><creatorcontrib>Komatsu, Masamichi</creatorcontrib><creatorcontrib>Sato, Masako</creatorcontrib><creatorcontrib>Tanaka, Jun</creatorcontrib><creatorcontrib>Takiguchi, Hiroto</creatorcontrib><creatorcontrib>Tomomatsu, Hiromi</creatorcontrib><creatorcontrib>Tomomatsu, Katsuyoshi</creatorcontrib><creatorcontrib>Hayama, Naoki</creatorcontrib><creatorcontrib>Oguma, Tsuyoshi</creatorcontrib><creatorcontrib>Aoki, Takuya</creatorcontrib><creatorcontrib>Urano, Tetsuya</creatorcontrib><creatorcontrib>Takagi, Atsushi</creatorcontrib><creatorcontrib>Asano, Koichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horio, Yukihiro</au><au>Takihara, Takahisa</au><au>Niimi, Kyoko</au><au>Komatsu, Masamichi</au><au>Sato, Masako</au><au>Tanaka, Jun</au><au>Takiguchi, Hiroto</au><au>Tomomatsu, Hiromi</au><au>Tomomatsu, Katsuyoshi</au><au>Hayama, Naoki</au><au>Oguma, Tsuyoshi</au><au>Aoki, Takuya</au><au>Urano, Tetsuya</au><au>Takagi, Atsushi</au><au>Asano, Koichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series</atitle><jtitle>Respiratory investigation</jtitle><addtitle>Respir Investig</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>54</volume><issue>2</issue><spage>125</spage><epage>129</epage><pages>125-129</pages><issn>2212-5345</issn><eissn>2212-5353</eissn><abstract>Abstract We report 3 cases (all men, age: 69–81 years) of acute exacerbation of interstitial pneumonia (AEIP) that were successfully treated with a high-flow nasal cannula (HFNC), which delivers heated, humidified gas at a fraction of inspired oxygen (FIO2 ) up to 1.0 (100%). Oxygenation was insufficient under non-rebreathing face masks; however, the introduction of HFNC with an FIO2 of 0.7–1.0 (flow rate: 40 L/min) improved oxygenation and was well-tolerated until the partial pressure of oxygen in blood/FIO2 ratio increased (between 21 and 26 days). Thus, HFNC might be an effective and well-tolerated therapeutic addition to the management of AEIP.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26879483</pmid><doi>10.1016/j.resinv.2015.09.005</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2212-5345 |
| ispartof | Respiratory investigation, 2016-03, Vol.54 (2), p.125-129 |
| issn | 2212-5345 2212-5353 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1765918075 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Acute Disease Acute exacerbation Acute respiratory failure Aged Aged, 80 and over Cannula Disease Progression High-flow nasal cannula Humans Internal Medicine Interstitial pneumonia Lung Diseases, Interstitial - therapy Male Oxygen Inhalation Therapy - instrumentation Oxygen Inhalation Therapy - methods Oxygen therapy Pulmonary/Respiratory Treatment Outcome |
| title | High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T16%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-flow%20nasal%20cannula%20oxygen%20therapy%20for%20acute%20exacerbation%20of%20interstitial%20pneumonia:%20A%20case%20series&rft.jtitle=Respiratory%20investigation&rft.au=Horio,%20Yukihiro&rft.date=2016-03-01&rft.volume=54&rft.issue=2&rft.spage=125&rft.epage=129&rft.pages=125-129&rft.issn=2212-5345&rft.eissn=2212-5353&rft_id=info:doi/10.1016/j.resinv.2015.09.005&rft_dat=%3Cproquest_cross%3E1765918075%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1765918075&rft_id=info:pmid/26879483&rft_els_id=S221253451500115X&rfr_iscdi=true |